Sign in
Taking people in United StatesNo phase

Pilot Study of BCAA on Sleep

Key facts

Who runs it
Portland VA Medical Center
Where
Portland, United StatesSee the site
Trial code
Status
Recruiting
People taking part
300 people, planned
Started
1 Mar 2019
Expected to end
1 Dec 2028
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Branched Chain Amino Acids
  • Rice Protein
  • Microcrystalline Cellulose
Record updated
17 September 2026

Who can take part

Age
18 years to 89 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Veteran
  • English Speaking
  • Accessible via phone
  • Sleep problems

Who cannot take part

  • Currently taking BCAAs
  • Decisional impairment
  • Nickel allergy
  • Maple syrup urine disease or family history of disease
  • Allergy to sucralose

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sleep disorder or traumatic brain injury

This trial is currently available in United States.

  • VA Portland Health Care SystemPortland, United StatesContact: Miranda M Lim, MD, PhDTaking people

About the trial

What the trial wants to find out

Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experimental period.

The 3 groups in the trial

  • BCAAsTreatment being tested

    60 grams of BCAA (2:1:1 ratio of Leucine:Isoleucine:Valine) consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21 days (42 total drinks).

    Treatment: Branched Chain Amino Acids

  • Rice ProteinPlacebo, for comparison

    Rice protein control group: 60 grams of rice protein consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21 days (42 total drinks).

  • Microcrystalline CellulosePlacebo, for comparison

    Placebo control group: 60 grams of microcrystalline cellulose, consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21 days (42 total drinks).

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Pilot Study of Dietary Supplementation With Branched Chain Amino Acids on Sleep
Criteria questions
Built from NCT03990909, who can take part
Publications
Record updated
17 September 2026